290 related articles for article (PubMed ID: 26026120)
1. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
[TBL] [Abstract][Full Text] [Related]
2. Living-donor liver transplantation for hepatocellular carcinoma.
Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
[TBL] [Abstract][Full Text] [Related]
3. De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation.
Morita K; Taketomi A; Soejima Y; Ikegami T; Fukuhara T; Iguchi T; Nagata S; Sugimachi K; Gion T; Shirabe K; Maehara Y
Liver Transpl; 2009 Nov; 15(11):1412-6. PubMed ID: 19877253
[TBL] [Abstract][Full Text] [Related]
4. Aggressive combined resection of hepatic inferior vena cava, with replacement by a ringed expanded polytetrafluoroethylene graft, in living-donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
Matsuda H; Sadamori H; Shinoura S; Umeda Y; Yoshida R; Satoh D; Utsumi M; Onishi T; Yagi T
J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):719-24. PubMed ID: 20425126
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
6. Salvage living-donor liver transplantation for liver failure following definitive radiation therapy for recurrent hepatocellular carcinoma: a case report.
Kitajima T; Fujimoto Y; Hatano E; Nishida H; Ogawa K; Mori A; Okajima H; Kaido T; Nakamura A; Nagamatsu H; Uemoto S
Transplant Proc; 2015 Apr; 47(3):804-8. PubMed ID: 25891735
[TBL] [Abstract][Full Text] [Related]
7. Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing living-donor liver transplantation.
Majeed TA; Wai CT; Rajekar H; Lee KH; Wong SY; Leong SO; Singh R; Tay KH; Chen J; Tan KC
Transplant Proc; 2008 Oct; 40(8):2507-9. PubMed ID: 18929781
[TBL] [Abstract][Full Text] [Related]
8. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
9. Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
Sakai K; Okajima H; Koshino K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Ochiai T; Yoshimura N
Transplant Proc; 2012 Mar; 44(2):409-11. PubMed ID: 22410029
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
[TBL] [Abstract][Full Text] [Related]
11. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma.
Abdel-Wahab M; Sultan AM; Fathy OM; Salah T; Elshobary MM; Elghawalby NA; Yassen AM; Elsarraf WM; Elsaadany MF; Zalatah K
Hepatogastroenterology; 2013; 60(128):1847-53. PubMed ID: 24719918
[TBL] [Abstract][Full Text] [Related]
15. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
[TBL] [Abstract][Full Text] [Related]
16. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
[TBL] [Abstract][Full Text] [Related]
17. Section 2. Small-for-size liver graft and hepatocellular carcinoma recurrence.
Chan SC
Transplantation; 2014 Apr; 97 Suppl 8():S7-S10. PubMed ID: 24849840
[TBL] [Abstract][Full Text] [Related]
18. Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation.
Taketomi A; Fukuhara T; Morita K; Kayashima H; Ninomiya M; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Shirabe K; Maehara Y
Ann Surg Oncol; 2010 Sep; 17(9):2283-9. PubMed ID: 20204531
[TBL] [Abstract][Full Text] [Related]
19. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma.
Hwang S; Lee SG; Moon DB; Ahn CS; Kim KH; Lee YJ; Ha TY; Song GW
Liver Transpl; 2007 May; 13(5):741-6. PubMed ID: 17457860
[TBL] [Abstract][Full Text] [Related]
20. (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
Lee SD; Kim SH; Kim YK; Kim C; Kim SK; Han SS; Park SJ
Transpl Int; 2013 Jan; 26(1):50-60. PubMed ID: 23106431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
